GALDERMA GROUP AG

36.43+0.26 (+0.72%)
Oct 29, 4:00:00 PM EDT · OTC Markets OTCPK · GALDY · USD

Upcoming Earnings

Report date
-

Key Stats

Market Cap
42.77B
P/E (TTM)
113.84
Basic EPS (TTM)
0.32
Dividend Yield
0%

About

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.

CEO
Dr. Flemming Ornskov M.B.A., M.D., M.P.H.
IPO
7/8/2024
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic